PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
35,979,894
Share change
+18,897
Total reported value
$139,965,345
Put/Call ratio
29250%
Price per share
$3.89
Number of holders
41
Value change
+$73,406
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q4 2013

As of 31 Dec 2013, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,979,894 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Allianz Asset Management AG, BAILLIE GIFFORD & CO, Camber Capital Management LLC, BlackRock Advisors LLC, DAFNA Capital Management LLC, FMR LLC, MENORA MIVTACHIM HOLDINGS LTD., GREAT POINT PARTNERS LLC, and First Eagle Investment Management, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.